These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7700948)

  • 1. Behavioral effects of the reversible dopamine antagonist flupenthixol are not potentiated by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in the preweanling rat.
    McDougall SA; Bolanos CA
    Pharmacol Biochem Behav; 1995 Jan; 50(1):127-31. PubMed ID: 7700948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogenetic differences in the effects of EEDQ on dopamine-mediated behaviors.
    Mestlin M; McDougall SA
    Pharmacol Biochem Behav; 1993 Aug; 45(4):797-802. PubMed ID: 8105488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats.
    Der-Ghazarian T; Gutierrez A; Varela FA; Herbert MS; Amodeo LR; Charntikov S; Crawford CA; McDougall SA
    Neuroscience; 2012 Dec; 226():427-40. PubMed ID: 23000622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogenetic effects of EEDQ on amphetamine-induced behaviors of rats: role of presynaptic processes.
    Crawford CA; McDougall SA; Bardo MT
    Psychopharmacology (Berl); 1994 Oct; 116(2):152-60. PubMed ID: 7862944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor.
    Der-Ghazarian T; Widarma CB; Gutierrez A; Amodeo LR; Valentine JM; Humphrey DE; Gonzalez AE; Crawford CA; McDougall SA
    Psychopharmacology (Berl); 2014 Feb; 231(4):651-62. PubMed ID: 24057816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of dopamine receptor inactivation during the adolescent period: age-dependent changes in dorsal striatal D2(High) receptors.
    McDougall SA; Valentine JM; Gonzalez AE; Humphrey DE; Widarma CB; Crawford CA
    Psychopharmacology (Berl); 2014 Apr; 231(8):1637-47. PubMed ID: 24287603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.
    McDougall SA; Crawford CA; Nonneman AJ
    Psychopharmacology (Berl); 1992; 106(4):502-10. PubMed ID: 1349753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors.
    McDougall SA; Crawford CA; Nonneman AJ
    Psychopharmacology (Berl); 1993; 111(2):225-32. PubMed ID: 7870957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.
    Crawford CA; McDougall SA; Bardo MT
    Neuropharmacology; 1994 Dec; 33(12):1559-65. PubMed ID: 7760979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent effects of dopamine receptor inactivation on cocaine-induced behaviors in male rats: Evidence of dorsal striatal D2 receptor supersensitivity.
    Crawford CA; Teran A; Ramirez GI; Katz CG; Mohd-Yusof A; Eaton SE; Real V; McDougall SA
    J Neurosci Res; 2019 Dec; 97(12):1546-1558. PubMed ID: 31304635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF; Waszczak BL
    Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
    Ekman A; Eriksson E
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):152-7. PubMed ID: 1360151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
    Undie AS; Berki AC; Beardsley K
    Neuropharmacology; 2000; 39(1):75-87. PubMed ID: 10665821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gangliosides facilitate the recovery of behavioral response mediated by dopaminergic sites following their irreversible blockade.
    Keller EA; Molina VA
    Brain Res Bull; 1993; 31(1-2):161-3. PubMed ID: 8453485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.